-
Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway
引用产品:肝癌组织芯片发表于Pubmed ID:IF: 8.756
基因ID:Species:Application:
-
Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway
引用产品:肝癌组织芯片发表于Pubmed ID:IF: 8.756
基因ID:Species:Application:
-
Low Expression of LDHB Correlates With Unfavorable Survival in Hepatocellular Carcinoma
引用产品:肝癌组织芯片发表于Pubmed ID:IF: 1.817
基因ID:Species:Application:
-
miR-706 inhibits the oxidative stress-induced activation of PKCα/ TAOK1 in liver fibrogenesis
引用产品:肝癌组织芯片发表于Pubmed ID:IF: 4.996
基因ID:Species:Application:
-
PRDM8 Exhibits Anti-Tumor Activities Toward Hepatocellular Carcinoma by Targeting NAP1L1
引用产品:肝癌组织芯片发表于Pubmed ID:IF: 17.298
基因ID:Species:Application:
-
Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal
引用产品:肝癌组织芯片发表于Pubmed ID:IF: 3.322
基因ID:Species:Application:
-
NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2
引用产品:肝HCC组织芯片发表于Pubmed ID:IF: 7.109
基因ID:Species:Application:
-
Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/
引用产品:肝HCC组织芯片 (5)发表于Pubmed ID:IF: 7.316
基因ID:Species:Application:
-
Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/
引用产品:肝HCC组织芯片 (4)发表于Pubmed ID:IF: 7.316
基因ID:Species:Application:
-
NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2
引用产品:肝HCC组织芯片 (3)发表于Pubmed ID:IF: 7.109
基因ID:Species:Application: